Anti-Angiogenesis Therapy in Ovarian Cancer: Which Patient is It Most Likely to Benefit?

Anca Chelariu-Raicu, Robert L. Coleman, Anil K. Sood

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-Angiogenesis Therapy in Ovarian Cancer: Which Patient is It Most Likely to Benefit?'. Together they form a unique fingerprint.

Medicine & Life Sciences